11.02.17
Constantia Flexibles has successfully completed the sale of its Labels division to Multi-Color Corporation for an enterprise value of approximately €1.15 billion ($1.3 billion). All required regulatory authorities have cleared the transaction. Constantia Flexibles has received approximately €830 million in cash and will continue to participate in the future success story of Multi-Color through a 16.6% shareholding.
The transaction brings together the Food and Beverage business of Constantia Flexibles’ Labels division with Multi-Color’s Wine & Spirit and Home & Personal Care platforms, as well as an emerging global position in Healthcare. The combined annual revenues of the two businesses will be approximately $1.7 billion.
“We would like to thank all employees of the Labels division for their tremendous contributions to our Group in the past and wish them a successful future as part of Multi-Color,” Alexander Baumgartner, CEO of Constantia Flexibles, said. “Constantia Flexibles will use the proceeds from the transaction to deleverage its balance sheet and enable further acquisitions in the dynamic and consolidating flexible packaging industry. We will also focus on innovative products and services, as well as new technologies to strengthen our existing Food and Pharma businesses.”
The transaction brings together the Food and Beverage business of Constantia Flexibles’ Labels division with Multi-Color’s Wine & Spirit and Home & Personal Care platforms, as well as an emerging global position in Healthcare. The combined annual revenues of the two businesses will be approximately $1.7 billion.
“We would like to thank all employees of the Labels division for their tremendous contributions to our Group in the past and wish them a successful future as part of Multi-Color,” Alexander Baumgartner, CEO of Constantia Flexibles, said. “Constantia Flexibles will use the proceeds from the transaction to deleverage its balance sheet and enable further acquisitions in the dynamic and consolidating flexible packaging industry. We will also focus on innovative products and services, as well as new technologies to strengthen our existing Food and Pharma businesses.”